The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Detection of microbial DNA in the blood of colorectal cancer patients for the diagnosis of microbial translocation.
 
Ioannis Sougklakos
Consulting or Advisory Role - Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst)
Speakers' Bureau - Sanofi; Sanofi; Sanofi; Sanofi
Research Funding - Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; SERVIER; SERVIER; SERVIER; SERVIER; SERVIER; SERVIER; SERVIER; SERVIER
 
Ippokratis Messaritakis
No Relationships to Disclose
 
Konstantinos Vogiatzoglou
No Relationships to Disclose
 
Konstantina Tsantaki
No Relationships to Disclose
 
Agapi Dretaki
No Relationships to Disclose
 
Asimina Koulouridi
No Relationships to Disclose
 
Maria Sfakianaki
No Relationships to Disclose
 
Andreas Vasileios Koulouris
No Relationships to Disclose
 
Maria Tzardi
No Relationships to Disclose
 
Dimitrios Mavroudis
No Relationships to Disclose
 
Ioannis Boukovinas
Employment - Pierre Fabre (I); Pierre Fabre (I); Pierre Fabre (I); Pierre Fabre (I)
Honoraria - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; LEO Pharma; LEO Pharma; LEO Pharma; LEO Pharma; Merck; Merck; Merck; Merck; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Genesis Pharma; Genesis Pharma; Genesis Pharma; Genesis Pharma; Ipsen; Ipsen; Ipsen; Ipsen; LEO Pharma; LEO Pharma; LEO Pharma; LEO Pharma; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi
Research Funding - Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; Lilly; Lilly; Lilly; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer; Regeneron; Regeneron; Regeneron; Regeneron; Roche; Roche; Roche; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD; MSD; MSD; MSD; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche